|
|
 |
|
|
 |
 |
Corporate Structure |
| Corporate reorganisation at Olympus Europa GmbH |
|
|
|
|
Worldwide |
| You can find information on the worldwide Olympus Group on the Olympus Global Website |
|
|
|
|
Key figures |
| Download the key figures chart (pdf) here |
|
|
|
|
International success
"Olympus owes its international success to its innovative engineers and its management creativity. The willingness to explore new ideas is one of the values central to Olympus."
"Olympus Management"
|
|
Double digit growth
Despite the difficult overall economic conditions, the Olympus Europe Group was able to sustain the extremely positive developments of previous years. This led to a record breaking result for the 2003/2004 financial year, with revenues growing 17.7 % to reach 1,431 million Euro.
| |
03/04 |
02/03 |
01/02* |
00/01* |
99/00* |
Number of fully
consolidated companies |
41 |
25 |
27 |
23 |
20 |
| Sales Revenues |
|
|
|
|
|
| Imaging Systems |
804.3 |
617.1 |
543.3 |
512.9 |
433.7 |
| Medical systems |
414.7 |
398.7 |
550.1 |
472.4 |
411.5 |
| Life Science - Microscopy |
78.5 |
81.9 |
83.3 |
72.9 |
61.4 |
| Life Science - Diagnostica |
133.5 |
118.0 |
104.4 |
84.7 |
73.4 |
| Total |
1,431.0 |
1,215.7 |
1,281.1 |
1,142.9 |
980.0 |
| Domestic (Germany) |
293.5 |
282.0 |
277.2 |
255.8 |
243.0 |
| Other countries |
1,137.5 |
933.7 |
1,003.9 |
887.1 |
737.0 |
| Gross profit on sale |
420.8 |
359.7 |
367.4 |
323.0 |
287.3 |
| Net Income (Loss) for the Year |
31.9 |
49.5 |
23.7 |
23.6 |
26.5 |
| in % of sale |
2.2 |
4.1 |
1.8 |
2.1 |
2.7 |
| Balance Sheet Total |
816.0 |
654.3 |
729.3 |
682.2 |
558.4 |
| Fixed assets |
176.2 |
132.0 |
153.1 |
127.2 |
99.6 |
| in % |
21.6 |
20.2 |
21.0 |
18.6 |
17.8 |
| Current assets |
626.7 |
511.6 |
562.2 |
545.4 |
447.4 |
| in % |
76.8 |
78.2 |
77.1 |
79.9 |
80.1 |
| - of switch inventories |
215.5 |
197.0 |
212.4 |
214.8 |
171.5 |
| in % |
26,4 |
30.1 |
29.1 |
31.5 |
30.7 |
| Equity |
198,9 |
168.0 |
220.3 |
195.0 |
175.1 |
| in % |
24.4 |
25.7 |
30.2 |
28.6 |
31.4 |
| - of which subscribed capital |
100.0 |
29.1 |
29.1 |
29.1 |
29.1 |
| in % |
12.3 |
4.4 |
4.0 |
4.3 |
5.2 |
| Liabilities (incl. accruals) |
615.4 |
484.8 |
508.2 |
485.8 |
381.5 |
| in % |
75.4 |
74.1 |
69.7 |
71.2 |
68.3 |
| - of which long-terms |
13.8 |
19.2 |
18.6 |
21.8 |
21.7 |
| - of which short-terms |
601.6 |
465.6 |
489.6 |
464.0 |
359.8 |
| Investment volume |
32.8 |
29.5 |
25.5 |
27.5 |
19.2 |
| Depreciation (tangilbe assets) |
31.5 |
27.0 |
30.0 |
21.1 |
26.4 |
| Employees (qualifing date) |
|
|
|
|
|
| Domestic (Germany) |
1,435 |
1,430 |
1,307 |
1,250 |
1,203 |
| Other countries |
1,988 |
1,630 |
2,296 |
1,995 |
1,808 |
| Total |
3,423 |
3,060 |
3,603 |
3,245 |
3,011 |
| Personnel expenses |
177.0 |
172.9 |
179.3 |
160.7 |
145.8 |
| in % |
12.4 |
14.2 |
14.0 |
14.1 |
14.9 |
| Sales by Markets |
|
|
|
|
|
| Germany |
293.5 |
282.0 |
277.2 |
255.8 |
243.0 |
| Great Britain |
198.1 |
156.3 |
283.6 |
250.3 |
204.2 |
| France |
169.6 |
144.8 |
128.6 |
122.4 |
111.9 |
| Rest of Europe |
708.2 |
586.4 |
508.5 |
424.6 |
349.1 |
| Outside Eurpe |
61.6 |
46.2 |
83.2 |
89.8 |
71.8 |
| Total |
1,431.0 |
1,215.7 |
1,281.1 |
1,142.9 |
980.0 |
* Figures from the previous year have not been adjusted to take the disposal of the KeyMed Group into account. |
|
 Top |
|
